Neuronetics, Inc. (STIM): Cash & Equivalents
$28.13M
As of 2025-12-31
$19.20M
As of 2026-06-30
-26.3%
3-year compound annual growth
-10.5%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $28.13M | +52.4% | 2026-03-17, Balance as of period end |
| 2024-12-31 | $18.46M | -69.1% | 2026-03-17, Balance as of period end |
| 2023-12-31 | $59.68M | -15.2% | 2026-03-17, Balance as of period end |
| 2022-12-31 | $70.34M | -25.3% | 2025-03-27, Balance as of period end |
| 2021-12-31 | $94.14M | +92.3% | 2023-03-07, Balance as of period end |
| 2020-12-31 | $48.96M | -35.3% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $75.71M | -27.6% | 2021-03-02, Balance as of period end |
| 2018-12-31 | $104.58M | +258.8% | 2020-03-03, Balance as of period end |
| 2017-12-31 | $29.15M | n/a | 2019-03-05, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | 2025-12-31 | $28.13M | +52.4% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $3.19M | +504.6% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $17.05M | +175.1% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $44.78M | -12.8% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $199.28M | -25.6% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $57.48M | +3.3% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $42.24M | +20.9% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $10.71M | -5.7% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $31.58M | +3.8% |
Compare STIM, INFU, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗